This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lupin, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Sandeep Somani: Innovator in Antibody Refolding Processes
Introduction
Sandeep Somani is a notable inventor based in Pune, India. He has made significant contributions to the field of biotechnology, particularly in the development of processes related to antibody fragments. His innovative work has implications for the pharmaceutical industry, enhancing the quality of therapeutic proteins.
Latest Patents
Sandeep Somani holds a patent for a "Refolding process for antibody's fragments." This patent describes a method for refolding Ranibizumab, a monoclonal antibody. The process involves treating a solubilized solution of heavy and/or light chains of Ranibizumab with a refolding buffer under specific conditions, including pH, temperature, and incubation period. The method also includes a pH and temperature shift performed at suitable intervals to achieve high quality and quantity of refolded protein. He has 1 patent to his name.
Career Highlights
Sandeep is currently employed at Lupin, Inc., a prominent player in the pharmaceutical industry. His role involves research and development, focusing on biopharmaceuticals and innovative drug formulations. His expertise in antibody technology has positioned him as a valuable asset to his team.
Collaborations
Throughout his career, Sandeep has collaborated with several professionals in the field. Notable coworkers include Ashish Pandey and Ashok Mishra, who have contributed to various projects alongside him.
Conclusion
Sandeep Somani's work in the refolding process of antibody fragments showcases his innovative spirit and dedication to advancing biotechnology. His contributions are vital for improving therapeutic proteins, making a significant impact in the pharmaceutical sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
